American Journal of Cardiology
Volume 96, Issue 10 , Pages 1361-1364, 15 November 2005

Effect of Intensive Versus Moderate Lipid Lowering on Endothelial Function and Vascular Responsiveness to Angiotensin II in Stable Coronary Artery Disease

  • Pim van der Harst, MD

      Affiliations

    • Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel: 31-50-361-2810; fax: 31-50-363-2812.
    • ,
  • Lodewijk J. Wagenaar, MD, PhD

      Affiliations

    • Department of Cardiology, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands
    • ,
  • Hendrik Buikema, PhD

      Affiliations

    • Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    • ,
  • Adriaan A. Voors, MD, PhD

      Affiliations

    • Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    • ,
  • H.W. Thijs Plokker, MD, PhD

      Affiliations

    • Department of Cardiology, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands
    • ,
  • Wim J. Morshuis, MD, PhD

      Affiliations

    • Department of Thorax Surgery, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands
    • ,
  • A. Jacob Six, MD, PhD

      Affiliations

    • Department of Cardiology, Hofpoort Hospital, Woerden, The Netherlands
    • ,
  • Piet W. Boonstra, MD, PhD

      Affiliations

    • Department of Cardiothorax Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    • ,
  • Georg Nickenig, MD

      Affiliations

    • Klinik und Poliklinik Innere Medizin III, Universitat des Saarlandes, Homburg, Germany.
    • ,
  • Sven Wassmann, MD

      Affiliations

    • Klinik und Poliklinik Innere Medizin III, Universitat des Saarlandes, Homburg, Germany.
    • ,
  • Dirk J. van Veldhuisen, MD, PhD

      Affiliations

    • Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    • ,
  • Wiek H. van Gilst, PhD

      Affiliations

    • Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Received 11 May 2005; received in revised form 7 July 2005; accepted 7 July 2005. published online 19 September 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported in part by a grand from Pfizer, Cappelle a/d IJssel, The Netherlands; Dr. van der Harst is supported by ZON-MW (920-03-236) of The Netherlands Organisation for Health Research and Development, The Netherlands; and Dr. van Veldhuisen received Grant D97-017 from the Netherlands Heart Foundation, The Netherlands.

PII: S0002-9149(05)01357-3

doi:10.1016/j.amjcard.2005.07.052

American Journal of Cardiology
Volume 96, Issue 10 , Pages 1361-1364, 15 November 2005

Article Tools

* Image Usage & Resolution